Literature DB >> 25087056

The value of acetylcholine receptor antibody in children with postural tachycardia syndrome.

Jiawei Li1, Qingyou Zhang, Ying Liao, Chunyu Zhang, Hongjun Hao, Junbao Du.   

Abstract

Postural tachycardia syndrome (POTS) is characterized by symptoms of orthostatic intolerance. Antibodies of acetylcholine receptor (AChR-ab) affect acetylcholine transmission between the ganglia and result in imbalance of the autonomic nervous system in POTS. This study was designed to analyze the clinical characteristics of POTS patients with AChR-ab positive and explore the value of AChR-ab in children with POTS. In 82 children with POTS, twenty patients (24.39%) were found as AChR-ab positive. Their clinical characteristics and hemodynamic responses to orthostatic changes were compared with the remaining 60 patients with negative AChR-ab. Symptoms of POTS children with AChR-ab positive were significantly severe than those of AChR-ab negative patients (p = 0.001). Preceding infection was predominant in patients with AChR-ab positive compared with that of patients with AChR-ab negative (p < 0.001). Syncope and fatigue were more common in the AChR-ab positive patients (p < 0.05). The change of upright heart rate was increased significantly in AChR-ab positive patients compared with AChR-ab negative cases (p = 0.013). Multiple logistic regression analysis revealed that preceding infection (OR 22.356, 95% CI 2.151-34.920), syncope (OR 11.570, 95% CI 2.098-63.810), and fatigue (OR 11.145, 95% CI 1.658-74.911) were independent risk factors for POTS with AChR-ab positive. In conclusion, POTS with positive AChR-ab was a heterogeneous disorder. Preceding infection, syncope and fatigue were their main clinical characteristics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25087056     DOI: 10.1007/s00246-014-0981-8

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  22 in total

Review 1.  The postural tachycardia syndrome: a concise guide to diagnosis and management.

Authors:  Blair P Grubb; Yousuf Kanjwal; Daniel J Kosinski
Journal:  J Cardiovasc Electrophysiol       Date:  2006-01

2.  Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome.

Authors:  Roy Freeman; Wouter Wieling; Felicia B Axelrod; David G Benditt; Eduardo Benarroch; Italo Biaggioni; William P Cheshire; Thomas Chelimsky; Pietro Cortelli; Christopher H Gibbons; David S Goldstein; Roger Hainsworth; Max J Hilz; Giris Jacob; Horacio Kaufmann; Jens Jordan; Lewis A Lipsitz; Benjamin D Levine; Phillip A Low; Christopher Mathias; Satish R Raj; David Robertson; Paola Sandroni; Irwin Schatz; Ron Schondorff; Julian M Stewart; J Gert van Dijk
Journal:  Clin Auton Res       Date:  2011-04       Impact factor: 4.435

3.  Twenty-four-hour urinary sodium excretion and postural orthostatic tachycardia syndrome.

Authors:  Qingyou Zhang; Ying Liao; Chaoshu Tang; Junbao Du; Hongfang Jin
Journal:  J Pediatr       Date:  2012-03-14       Impact factor: 4.406

Review 4.  Postural orthostatic tachycardia syndrome: a clinical review.

Authors:  Jonathan N Johnson; Kenneth J Mack; Nancy L Kuntz; Chad K Brands; Coburn J Porter; Philip R Fischer
Journal:  Pediatr Neurol       Date:  2010-02       Impact factor: 3.372

5.  Postural tachycardia in children and adolescents: what is abnormal?

Authors:  Wolfgang Singer; David M Sletten; Tonette L Opfer-Gehrking; Chad K Brands; Philip R Fischer; Phillip A Low
Journal:  J Pediatr       Date:  2011-10-11       Impact factor: 4.406

6.  Diagnostic management of orthostatic intolerance in the workplace.

Authors:  R Winker; A Barth; W Dorner; O Mayr; A Pilger; S Ivancsits; I Ponocny; A Heider; C Wolf; H W Rüdiger
Journal:  Int Arch Occup Environ Health       Date:  2002-10-30       Impact factor: 3.015

7.  Antibody titers predict clinical features of autoimmune autonomic ganglionopathy.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Auton Neurosci       Date:  2009-01-13       Impact factor: 3.145

Review 8.  Postural tachycardia syndrome (POTS).

Authors:  Phillip A Low; Paola Sandroni; Michael Joyner; Win-Kuang Shen
Journal:  J Cardiovasc Electrophysiol       Date:  2009-01-16

9.  Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current.

Authors:  Z Wang; P A Low; J Jordan; R Freeman; C H Gibbons; C Schroeder; P Sandroni; S Vernino
Journal:  Neurology       Date:  2007-05-29       Impact factor: 9.910

10.  Autoimmunoreactive IgGs against cardiac lipid raft-associated proteins in patients with postural orthostatic tachycardia syndrome.

Authors:  Xiao-Li Wang; Tian-You Ling; M Cristine Charlesworth; Juan J Figueroa; Phillip Low; Win-Kuang Shen; Hon-Chi Lee
Journal:  Transl Res       Date:  2013-04-03       Impact factor: 7.012

View more
  8 in total

Review 1.  Autonomic dysfunction and HPV immunization: an overview.

Authors:  Svetlana Blitshteyn; Louise Brinth; Jeanne E Hendrickson; Manuel Martinez-Lavin
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

2.  Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial.

Authors:  Jangsup Moon; Do-Yong Kim; Woo-Jin Lee; Han Sang Lee; Jung-Ah Lim; Tae-Joon Kim; Jin-Sun Jun; Byeongsu Park; Jung-Ick Byun; Jun-Sang Sunwoo; Soon-Tae Lee; Keun-Hwa Jung; Kyung-Il Park; Ki-Young Jung; Manho Kim; Sang Kun Lee; Kon Chu
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

Review 3.  Autoimmune autonomic neuropathies and ganglionopathies: epidemiology, pathophysiology, and therapeutic advances.

Authors:  Elisabeth P Golden; Steven Vernino
Journal:  Clin Auton Res       Date:  2019-05-15       Impact factor: 4.435

4.  gAChR antibodies in children and adolescents with acquired autoimmune dysautonomia in Japan.

Authors:  Makoto Yamakawa; Mari Watari; Ken-Ichi Torii; Ichiro Kuki; Masashi Miharu; Momoko Kawazu; Akihiro Mukaino; Osamu Higuchi; Yasuhiro Maeda; Tokunori Ikeda; Koutaro Takamatsu; Nozomu Tawara; Keiichi Nakahara; Hidenori Matsuo; Mitsuharu Ueda; Takao Takahashi; Shunya Nakane
Journal:  Ann Clin Transl Neurol       Date:  2021-02-23       Impact factor: 4.511

5.  Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1.

Authors:  Steven Vernino; Kate M Bourne; Lauren E Stiles; Blair P Grubb; Artur Fedorowski; Julian M Stewart; Amy C Arnold; Laura A Pace; Jonas Axelsson; Jeffrey R Boris; Jeffrey P Moak; Brent P Goodman; Kamal R Chémali; Tae H Chung; David S Goldstein; Andre Diedrich; Mitchell G Miglis; Melissa M Cortez; Amanda J Miller; Roy Freeman; Italo Biaggioni; Peter C Rowe; Robert S Sheldon; Cyndya A Shibao; David M Systrom; Glen A Cook; Taylor A Doherty; Hasan I Abdallah; Anil Darbari; Satish R Raj
Journal:  Auton Neurosci       Date:  2021-06-05       Impact factor: 2.355

Review 6.  Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessment.

Authors:  Brian Olshansky; David Cannom; Artur Fedorowski; Julian Stewart; Christopher Gibbons; Richard Sutton; Win-Kuang Shen; James Muldowney; Tae Hwan Chung; Suzy Feigofsky; Hemal Nayak; Hugh Calkins; David G Benditt
Journal:  Prog Cardiovasc Dis       Date:  2020-03-25       Impact factor: 11.278

Review 7.  Pubertal Hormonal Changes and the Autonomic Nervous System: Potential Role in Pediatric Orthostatic Intolerance.

Authors:  Kassandra E Coupal; Natalie D Heeney; Brooke C D Hockin; Rebecca Ronsley; Kathryn Armstrong; Shubhayan Sanatani; Victoria E Claydon
Journal:  Front Neurosci       Date:  2019-11-12       Impact factor: 4.677

8.  Serum Activity Against G Protein-Coupled Receptors and Severity of Orthostatic Symptoms in Postural Orthostatic Tachycardia Syndrome.

Authors:  Isabella Kharraziha; Jonas Axelsson; Fabrizio Ricci; Giuseppe Di Martino; Margaretha Persson; Richard Sutton; Artur Fedorowski; Viktor Hamrefors
Journal:  J Am Heart Assoc       Date:  2020-07-30       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.